Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lucrative Prospects for India-UK Pharma Trade (India)

This article was originally published in PharmAsia News

Executive Summary

A new study predicts India-U.K. trade will increase by 60 percent over the next three years, and that U.K. pharmaceutical companies in particular will see great outsourcing opportunities as well as investment opportunities in India. The report by the Federation of Indian Chambers of Commerce and Industry (FICCI) and Yes Bank will be released soon, and says that U.K.-India pharmaceutical cooperation should be strong especially in the fields of clinical trials, generic drug production, business and data process outsourcing, and some targeted marketing opportunities. Today India's pharmaceutical industry is ranked fourth worldwide in volume and thirteenth worldwide in value. India's pharmaceutical industry generates around $10 billion annually, China around $11 billion annually, Japan around $60 billion annually, and the United States around $263 billion annually. Indian officials hope to surpass China in the near future. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts